Could a Narrow-Spectrum antibiotic beat gonorrhea without fueling superbugs?

NCT ID NCT07631364

First seen Jun 14, 2026 · Last updated Jun 14, 2026

Summary

This study compares temocillin, a targeted antibiotic, to the standard treatment ceftriaxone for gonorrhea infections. About 360 adults with asymptomatic gonorrhea will receive either drug to see if temocillin works just as well while causing less harm to gut bacteria and reducing the risk of antibiotic resistance. The goal is to find a treatment that is both effective and safer for long-term microbial health.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEISSERIA GONORRHOEAE (NG) INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Service des maladies infectieuses et tropicales, Hôpital Saint-Antoine, GHU AP-HP Sorbonne Université

    Paris, 75012, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.